• Loma Linda University School of Allied Health – Challenges in the Management of Sickle Cell Disease: Bringing Science to Bedside. March 2018 (03/2018)
  • Non Profit “PossAbilities” Southern California: Annual Scientific Invited Lecture 2021 “Sickle Cell Disease Challenges in the COVID 19 pandemic” (08/2021)
  • UCLA Medical Center, Department of Pediatric Hematology Oncology invited lecture- “Advances in Hemophilia Care – New Horizons”    (01/2022)
  • Children’s Mercy, University of Kansas: Invited talk “Sickle Cell Disease in 2022: Advances in the past 5 decades”. (11/2022)
  • Grand Rounds : Loma Linda University, Department of Medicine: Grand Rounds on “Advances in Bleeding Disorder Management”. (11/2022)


  • Rotary Club of America : "Advances in Childhood Blood and Cancer care treatments in 2022." (05/2022)
  • Prophy Conference , Dallas : Gene therapy and Hemophilia: How to have educated decisions with your providers, a townhall on patient empowerment and Advocacy. 6/2/2023 (06/2023)


  • Reactivation of factor 8 inhibitor on emicizumab prophylaxis in a previously tolerized patient. Abstract : PWH with history of inhibitors need to be closely watched for the resurgence of inhibitors while on bypassing therapies, as subsequent exposure to recombinant factor product may pose a immune "re-challenge" that needs close surveillance.   (03/2023)


  • Leukemia and Beyond: Advances in Cancer Care and Blood Disorders in the 21st Century (10/2019 - 05/2020)
  • Global Corona Virus Pandemic Preparedness Response for Medical Association of physicians of Indian Origin- The Hematology Oncology Perspective and novel findings.  (04/2020 - 05/2020)
  • Ministry of Health, Government of India Invited Annual B.N. Rao Oration – “Sickle Cell Disease, Past Present and the Future: a Global perspective” (12/2021)
  • Australia Sickle Cell Society Inaugral oration - “COVID 19 Vaccination in Sickle Cell Disease”, Melbourne, Australia. (04/2022)
  • Noon Conference for Pediatric Residency Program LLUCH : Management of Sickle Cell Disease .  (05/2023)
  • WIL33 - International soceity of Hemostasis Thrombosis meeting.  HTRS/ISTH Symposium as program faculty  (06/2023)